1. Home
  2. ANAB vs ARCO Comparison

ANAB vs ARCO Comparison

Compare ANAB & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$50.91

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Arcos Dorados Holdings Inc. Shares

ARCO

Arcos Dorados Holdings Inc. Shares

HOLD

Current Price

$7.19

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
ARCO
Founded
2005
2007
Country
United States
Uruguay
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
ANAB
ARCO
Price
$50.91
$7.19
Analyst Decision
Buy
Hold
Analyst Count
12
2
Target Price
★ $71.67
$8.60
AVG Volume (30 Days)
469.9K
★ 967.1K
Earning Date
05-08-2026
05-20-2026
Dividend Yield
N/A
★ 3.23%
EPS Growth
★ 91.02
N/A
EPS
N/A
★ N/A
Revenue
★ $234,603,000.00
N/A
Revenue This Year
N/A
$12.56
Revenue Next Year
$52.14
$3.48
P/E Ratio
★ N/A
$7.26
Revenue Growth
★ 157.01
N/A
52 Week Low
$23.15
$6.54
52 Week High
$73.30
$9.75

Technical Indicators

Market Signals
Indicator
ANAB
ARCO
Relative Strength Index (RSI) 34.85 26.79
Support Level $50.09 $7.09
Resistance Level $51.67 $8.50
Average True Range (ATR) 2.45 0.18
MACD -0.41 -0.07
Stochastic Oscillator 16.64 2.80

Price Performance

Historical Comparison
ANAB
ARCO

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About ARCO Arcos Dorados Holdings Inc. Shares

Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Its menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others. It generates maximum revenue from Brazil.

Share on Social Networks: